Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6806021 | 0.77 | TAAR1 (0.40) | — | |
| SCHEMBL28005921 | 0.76 | SMN1; SMN2 (0.33) | CA1CA2CA4CA9 | |
| SCHEMBL9559746 | 0.76 | SMN1; SMN2 (0.30) | — | |
| SCHEMBL11039473 | 0.76 | TAAR1 (0.36) | — | |
| SCHEMBL9559727 | 0.75 | TAAR1 (0.36) | — | |
| SCHEMBL62392 | 0.74 | CA1 (0.35) | CA1CA2CA4CA9 | |
| SCHEMBL8322161 | 0.73 | CA1 (0.41) | CA1CA2CA4CA9 | |
| SCHEMBL7216627 | 0.73 | CA1 (0.39) | CA1CA2CA4CA9 | |
| SCHEMBL651045 | 0.72 | CA1 (0.39) | CA1CA2CA4CA9 | |
| SCHEMBL10694186 | 0.71 | SMN1; SMN2 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116287120-A | Preservation solution capable of being preserved at normal temperature and preserving nucleic acid DNA and RNA of human cells in saliva sample at high temperature of 60 ℃ and preparation method thereof | 江苏康为世纪生物科技股份有限公司 | 2023-06-23 | — | — | CN | claimed |
| EP-4675276-A1 | METHOD FOR IMMUNOLOGICALLY MEASURING HEMOGLOBIN USING DEGLYCOSYLATED HAPTOGLOBIN | EIKEN KAGAKU KABUSHIKI KAISHA (JP) | 2026-01-07 | — | — | EP | disclosed |
| CN-116287120-B | Preservation solution capable of being preserved at normal temperature and preserving nucleic acid DNA and RNA of human cells in saliva sample at high temperature of 60 ℃ and preparation method thereof | 江苏康为世纪生物科技股份有限公司 | 2025-10-31 | — | — | CN | disclosed |
| EP-3761030-B1 | METHOD FOR STABILIZING PROTEIN CONTAINED IN SAMPLE AND SOLUTION FOR STABILIZING PROTEIN CONTAINED IN SAMPLE | EIKEN CHEMICAL (JP) | 2025-04-30 | — | — | EP | disclosed |
| CN-119061004-B | Microbial flora nucleic acid DNA preservation solution for sputum sample | 北京市疾病预防控制中心 | 2025-02-14 | — | — | CN | disclosed |
| US-12215140-B2 | Method of stabilizing protein contained in specimen and solution for stabilizing protein contained in specimen | EIKEN KAGAKU KABUSHIKI KAISHA (JP) | 2025-02-04 | — | — | US | disclosed |
| CN-119061004-A | Microbial flora nucleic acid DNA preservation solution for sputum sample | 北京市疾病预防控制中心 | 2024-12-03 | — | — | CN | disclosed |
| CN-111788484-B | Method for stabilizing protein contained in sample, solution for stabilizing protein contained in sample | 荣研化学株式会社 | 2024-11-19 | — | — | CN | disclosed |
| WO-2024181457-A1 | METHOD FOR IMMUNOLOGICALLY MEASURING HEMOGLOBIN USING DEGLYCOSYLATED HAPTOGLOBIN | 栄研化学株式会社 | 2024-09-06 | — | — | WO | disclosed |
| CN-116287120-A | Preservation solution capable of being preserved at normal temperature and preserving nucleic acid DNA and RNA of human cells in saliva sample at high temperature of 60 ℃ and preparation method thereof | 江苏康为世纪生物科技股份有限公司 | 2023-06-23 | — | — | CN | disclosed |
| EP-2944959-B1 | HEMOGLOBIN STABILIZING STORAGE SOLUTION | EIKEN CHEMICAL (JP) | 2016-11-30 | — | — | EP | disclosed |
| EP-2944959-A1 | Hemoglobin stabilizing storage solution | Eiken Chemical Co., Ltd. (JP) | 2015-11-18 | — | — | EP | disclosed |
| US-8562919-B2 | Feces sampling container | KYOWA MEDEX CO., LTD. (JP) | 2013-10-22 | — | — | US | disclosed |
| US-8445719-B2 | Method of stabilizing heme protein and storage solution therefor | EIKEN CHEMICAL CO., LTD. (JP) | 2013-05-21 | — | — | US | disclosed |
| US-20130004975-A1 | Method of Stabilizing Heme Protein and Storage Solution Therefor | EIKEN CHEMICAL CO., LTD. (JP) | 2013-01-03 | — | — | US | disclosed |
| US-8329943-B2 | Method of stabilizing heme protein and storage solution therefor | EIKEN CHEMICAL CO., LTD. (JP) | 2012-12-11 | — | — | US | disclosed |
| EP-2375233-A1 | FECES-SAMPLING CONTAINER | Kyowa Medex CO., LTD. (JP) | 2011-10-12 | — | — | EP | disclosed |
| US-20110243816-A1 | FECES SAMPLING CONTAINER | KYOWA MEDEX CO., LTD. (JP) | 2011-10-06 | — | — | US | disclosed |
| US-20100216178-A1 | METHOD OF STABILIZING HEME PROTEIN AND STORAGE SOLUTION THEREFOR | EIKEN CHEMICAL CO., LTD. (JP) | 2010-08-26 | — | — | US | disclosed |
| EP-2204648-A1 | METHOD OF STABILIZING HEM PROTEIN AND STORAGE SOLUTION THEREFOR | Eiken Chemical Co., Ltd. (JP) | 2010-07-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100216178-A1 | METHOD OF STABILIZING HEME PROTEIN AND STORAGE SOLUTION THEREFOR | HMOX1, CYC1, COX15 | CA1 2176/4885CA2 728/4885CA4 3054/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.